Horváth Eszter Mária, Mágenheim Rita, Domján Beatrix Annamária, Ferencz Viktória, Tänczer Tímea, Szabó Eszter, Benkő Rita, Szabó Csaba, Tabák Ádám, Somogyi Anikó
Élettani Intézet, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Tűzoltó u. 37-47., 1094.
Klinikai Kísérleti Kutató- és Humán Élettani Intézet, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest.
Orv Hetil. 2015 Nov 22;156(47):1932-6. doi: 10.1556/650.2015.30307.
Oxidative-nitrative stress and poly(ADP-ribose) polymerase activation observed in gestational diabetes may play role in the increased cardiovascular risk in later life.
The present study aimed to examine the influence of the severity of previous gestational diabetes (insulin need) on vascular function three years after delivery. Furthermore, the authors investigated the relation of vascular function with oxidative-nitrative stress and poly(ADP-ribose) polymerase activation.
Macrovascular function was measured by applanation tonometry; microvascular reactivity was assessed by provocation tests during Laser-Doppler flowmetry in 40 women who had gestational diabetes 3 years before the study. Oxidative-nitrative stress and poly(ADP-ribose) polymerase activity in blood components were determined by colorimetry and immunohistochemistry.
Three years after insulin treated gestational diabetes impaired microvascular function and increased oxidative stress was observed compared to mild cases.
The severity of previous gestational diabetes affects microvascular dysfunction that is accompanied by elevated oxidative stress. Nitrative stress and poly(ADP-ribose) polymerase activity correlates with certain vascular factors not related to the severity of the disease.
妊娠期糖尿病中观察到的氧化-硝化应激和聚(ADP-核糖)聚合酶激活可能在晚年心血管风险增加中起作用。
本研究旨在探讨既往妊娠期糖尿病严重程度(胰岛素需求)对产后三年血管功能的影响。此外,作者还研究了血管功能与氧化-硝化应激和聚(ADP-核糖)聚合酶激活之间的关系。
对40名在研究前3年患有妊娠期糖尿病的女性,通过压平式眼压测量法测量大血管功能;在激光多普勒血流仪检查期间通过激发试验评估微血管反应性。通过比色法和免疫组织化学法测定血液成分中的氧化-硝化应激和聚(ADP-核糖)聚合酶活性。
与轻度病例相比,胰岛素治疗的妊娠期糖尿病三年后微血管功能受损且氧化应激增加。
既往妊娠期糖尿病的严重程度会影响微血管功能障碍,并伴有氧化应激升高。硝化应激和聚(ADP-核糖)聚合酶活性与某些与疾病严重程度无关的血管因素相关。